This could also happen with Ozempic, Wegovy, and other weight loss injectables
Partner with us to reflect your commitment to quality and market leadership
In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk
Facebook Instagram Youtube NOTICIAS LOCALES ESTADOS UNIDOS PUERTO RICO CUBA INMIGRACIN ENTRETENIMIENTO ACCESO TOTAL SALUD MUNDO Nuestros estndares de noticias Conoce a Telemundo Tampa Trminos de Servicio WRMD Public Inspection File Accesibilidad Empleos Aplicaciones de la FCC Enva tus comentarios Poltica de Privacidad Your Privacy Choices Aviso de California Opciones de anuncios Annciate con nosotros / Advertise with us Gua de programacin Copyright 2026 NBCUniversal Media, LLC
doi: 10.1007/s00125-016-3896-5 42
45.3% of participants achieved 30% weight loss